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Abstract 
Children with thalassemia major must be treated with life-long blood transfusions. Evidence suggests that 
patients with more knowledge/information about their illnesses adhere more readily to treatment schedules. 
However, there has been little evaluation of disease knowledge and treatment adherence in thalassemia major 
children. The objectives of the current study were to detect factors affecting the compliance of thalassemic 
children and their mothers and to identify the relationships between disease knowledge and treatment adherence 
in thalassemic children. A cross-sectional descriptive design and purposive sampling were used. fifty thalassemia 
major children (mean age 13.74 years) and their 50 mothers were recruited. structured questionnaire consisting 
of (A) personal Information; included, Socio-demographic and disease-related data were collected which 
included age, gender, educational level, (b) An assessment of disease knowledge about TM ; Assessment of 
disease knowledge of children and their mothers consisted of 20 open questions measuring children's and 
mothers' knowledge, treatment and compliance of treatment plan about TM. The result of this study revealed that 
that moderate commitment was apparent in 6%  of sample with week knowledge and 60% of sample with 
moderate knowledge while, strong commitment was found in 26% of sample with moderate knowledge and in 
8% of them with week knowledge. This relation was highly statistically significant (p= .000).Based on the 
findings of the current study, it can be concluded that, The positive association between knowledge about disease 
and treatment adherence and factors of patients’ knowledge indicate the need for systematic education for 
patients and caregivers to improve their compliance with treatment. The current study recommended that, the 
improvement of the quality of patient care, reinforcement of medical education and enhanced efforts by clinical 
staff to provide practical knowledge to children with thalassemia major and their parents is mandatory to 
significantly improve patient compliance to treatment. 
Keywords: thalassemia,compliance. 
 
1. Introduction 
Thalassemia is a genetic, autosomal recessive haemoglobinopathic disease, it is found worldwide, but most 
commonly in the Mediterranean, North Africa and South-East Asia (Faa et al. 2006). Beta thalassemia, a major 
type of thalassemia, is commonly caused by a defect of beta globin protein production. Beta thalassemia is 
divided into three categories: thalassemia trait, thalassemia intermedia and thalassemia major (TM). In first two 
categories, one of the beta globin genes fails and the amount of beta globin protein in the cell is reduced by half. 
In TM, the transfusion-dependent clinical phenotype of thalassemia, both genes fail and no beta globin protein is 
produced (Aydinok et al. 2005). 
 In Egypt carrier rate 5.3 - ≥ 9%, and 1000/1.5 million / year live births born with Thalassemia (total live births 
1,936,205 in 2006). Registered cases of homozygous beta thalassemia in big centers of Egypt in 2006 up to Sept 
2007 (n=9912) (El-Beshlawy, 2009). Mahmoud, (2009) added that there are 10,000 registered thalassemia cases 
and more than 20,000 non-registered cases. 95% are beta thalassemia major; 5% are thalassemia intermedia or 
hemoglobin H disease. Registered cases of homozygous beta thalassemia in Zagazig University Hospital in 2006 
up to Sept 2007 (n=710) (El-Beshlawy, 2009).  
Worldwide, 15 million people have clinically apparent thalassemic disorders. Reportedly, disorders worldwide, 
and people who carry thalassemia in India alone number approximately 30 million. These facts confirm that 
thalassemias are among the most common genetic disorders in humans; they are encountered among all ethnic 
groups and in almost every country around the world (Yaish, 2009).   
TM must be treated by life-long regular blood transfusions (Aessopos et al. 2005). Long-term blood transfusions 
may generate iatrogenic haemosiderosis, resulting in iron overload. Iron chelation therapy is the mandatory 
method of preventing organ damage resulting from the accumulation of iron in different tissues (Alymara et al. 
2004). Administration of desferrioxamine (DFO) is the primary iron-chelating agent used to treat iron overload 
(Beshlawy 2005). Iron accumulation can be fatal for TM patients. Most die as a result of complications caused 
Journal of Biology, Agriculture and Healthcare                                                                                                                                www.iiste.org 
ISSN 2224-3208 (Paper)  ISSN 2225-093X (Online) 
Vol.4, No.3, 2014 
 
43 
 
by ir on accumulation from blood transfusions, with 71% of deaths caused by congestive heart failure owing to 
iron accumulation in the heart (Cheung et al. 2005). In addition, cardiac disease, pulmonary hypertension 
(Aessopos et al. 2005), glucose metabolism disorders  and gonadal dysfunction can also result from iron 
overload in TM patients (Platis et al. 2004).  
Bone marrow transplantation (BMT) can provide TM patients with an improved chance of survival. Although, 
some patients have shown great improvement or been cured of TM as a result of BMT treatment, the rigid 
criteria for screening BMT candidates prevents widespread application of the therapy. Gene therapy is another 
possible cure for thalassemia (Lin 1997). However, research is still in the experimental stage. The DFO 
administration is a grueling process.  
Clinically, the investigators have observed that some patients did not adhere to regular treatment schedules. 
Excuses included: ‘It is inconvenient’, ‘I just don’t want to do it’, ‘it hurts’ and ‘since it leaked out, I don’t want 
to do it again’. Other reasons for unsatisfactory adherence to DFO treatment may be the cost and burden of daily 
administration (Aydinok et al. 2005). Patients’ knowledge about treatment and late effects have been shown to 
correlate with treatment adherence for many diseases. Studies show that patients with more knowledge of their 
illnesses are more compliant with treatment schedules: TM (Aydinok et al. 2005); AIDS (Kalichman et al. 2005); 
and asthma (Schaffer & Tian 2004). Furthermore, several theory-guided intervention studies suggest that the 
more the information provided to patients, the more were they compliant to treatment: AIDS (Amico et al. 2005), 
asthma (Schaffer & Tian 2004) and muscular dystrophy. Factors which affect patients’ compliance to treatment 
include individual patient knowledge, attitudes/beliefs, behavioural skills, perceptions of support from 
significant others, such as caregivers, the therapeutic environment (Amico et al. 2005).  
The objectives of the nursing care for children and adolescent with thalassemia start with promote adherence to 
treatment regimen, as well as support them during illness and distressing treatments,  in addition promote patient 
and family coping such as anticipate older children and adolescents concerns related to appearance and monitor 
closely for complications of the condition and treatment (Johnson, 2010). 
Aims of study: 
The current study aims to: (i) detect factors affecting the compliance of thalassemic children and their mothers; 
(ii) identify the relationships between disease knowledge and treatment adherence in thalassemic children. 
Research question: 
Is there a relationship between thalassemic children and their mothers knowledge about the disease and 
compliance to treatment?  
 
Research hypothesis: 
• The more the knowledge of the illness, the more adherence with treatment schedules. 
Methods 
Sample 
Cross-sectional descriptive design and purposive sampling were used. Eligible patients were chosen from TM 
patients who attended the out patient Pediatric Hematology clinic at Zagazig University Hospital in Zagazig 
City. Inclusion criteria were children with TM who: (i) were able to communicate with the researcher (ii) had no 
severe mental illness diagnosed by psychologists or psychiatrists; (iii) were 10 years or older; and (iv) gave 
informed consent. Fifty patients were potentially eligible. Patients of 10 years and older were included because 
they had already been treated for TM for several years and were expected to have TM-related knowledge to take 
care of themselves. After receiving informed consent, patients were individually administered a questionnaire by 
a researcher. Data from 50 patients and their mothers were used for analyses. 
Measure (tools):  
Data were collected by structured questionnaire consisting of:  
(a) A personal Information; included, Socio-demographic and disease-related data were collected 
which included age, gender, educational level, employment, monthly household income, 
haemoglobin level, duration and frequency of blood transfusions, duration and frequency of 
DFO infusions and importance and meaning of commitment to treatment plan. 
 
(b) An assessment of disease knowledge about TM ; Assessment of disease knowledge of children 
and their mothers consisted of 20 open questions measuring children's and mothers' knowledge, 
treatment and compliance of treatment plan about TM. Each item was scored using 0 , 1 , 2 (0 = 
incorrect/do not know; 1 = correct but incomplete, 2= correct and complete answer). A higher score 
represented a higher level of knowledge about TM and its treatment plan and importance of 
compliance and reasons for in commitment. The questionnaire was developed based on a literature 
review, personal clinical observations and suggestions from two paediatric haematologists. Two 
paediatric haematologists and two senior paediatric nurses examined the instrument for the 
appropriateness, representativeness and relevance. Face validity and content validity were used to 
Journal of Biology, Agriculture and Healthcare                                                                                                                                www.iiste.org 
ISSN 2224-3208 (Paper)  ISSN 2225-093X (Online) 
Vol.4, No.3, 2014 
 
44 
 
evaluate the questionnaire. Comments from the experts indicated that it was an appropriate measure 
for a construct of TM-related knowledge. Five children and their mothers in this study, were invited 
to pilot test the questionnaire. The pilot-study patients reported that the questionnaire was easy to 
understand.  
 
Procedure 
Questionnaires were administered to the target sample by a researcher as patients were receiving blood 
transfusions. Patients could ask questions during the process. Accompanying parents were told not to help with 
answers. Parents could sit beside patients during data collection and filled out the same questionnaire as the 
patients. mothers and children were informed that no individual’s identity would be disclosed and that they could 
refuse to answer any questions or to terminate the survey at any time. Informed consent was obtained prior to 
filling out the survey. The survey took about 10–15 minutes to complete. 
Analyses 
Data were analyzed using SPSS for Windows. Descriptive statistical methods were used. Pearson correlation was 
used to examine the relationships between patients’ knowledge and treatment adherence, some demographic and 
disease variables and parents’ knowledge. Perspectives of patients and family carers knowledge and adherence. 
Table (1): Socio-demographic characteristics of TM children and their mothers.  
Characteristics N (n=50) (%) 
Age Mean ± SD 13.74±2.107 
Sex  
Male  
Female  
 
33 
17 
 
66.0 
34.0 
Birth order  
First  
Second and third  
Forth or more  
 
16 
26 
8 
 
32.0 
52.0 
16.0 
Residence 
Urban  
       Rural 
 
20 
30 
 
40.0 
60.0 
Mothers age in years 
     20-30 
     30-40 
     ≥40 
 
20 
12 
18 
 
40.0 
24.0 
36.0 
Mother Education  
Illiterate 
Read & write 
Secondary 
University 
 
19 
6 
23 
2 
 
38.0 
12.0 
46.0 
4.0 
Mother Occupation 
      Working 
      Not working 
 
9 
41 
 
18.0 
82.0 
Family monthly income 
Sufficient and save  
Sufficient 
Insufficient 
 
6 
23 
21 
 
12.0 
46.0 
42.0 
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Table (2): Medical history and physical activity of TM children 
Medical History/ physical Activity N 
( n= 50 ) 
 
(%) 
Family history of thalassemia  
- Yes  
- No   
 
30 
20 
 
60.0 
40.0 
Consanguinity relation with thalassemic child   
- First degree 
- Second degree 
- Other 
 
18 
12 
20 
 
36.0 
24.0 
40.0 
Does the child practice sport or activity? 
 Yes 
 No  
 
22 
28 
 
44.0 
56.0 
Type of sport to be practiced 
 Walking 
 Running 
 Swimming 
 Football 
 None 
 
12 
2 
1 
7 
28 
 
32.0 
4.0 
2.0 
16.0 
56.0 
Is the child feel tired after exerting effort? 
 Yes 
 No  
 
44 
6 
 
88.0 
12.0 
Manifestation of child's tiredness: 
Headache 
Nausea 
Sweat 
Dyspnea 
None 
 
2 
8 
9 
25 
6 
 
4.0 
16.0 
18.0 
50.0 
12.0 
Table (3): knowledge of the TM children and their mothers about  the disease 
Factors Mothers 
( n= 50 ) 
TM children 
( n= 50) 
No % No % 
Definition of thalassemis 
- Don't know or incorrect 
- Correct but incomplete 
- Correct and complete 
 
32 
17 
1 
 
64.0 
34.0 
2.0 
 
38 
12 
0 
 
76.0 
24.0 
0.0 
Prevalence of thalassemia 
- Don't know or incorrect 
- Correct but incomplete 
- Correct and complete 
 
23 
0 
27 
 
46.0 
0.0 
54.0 
 
30 
0 
20 
 
60.0 
0.0 
40.0 
Risk factors of disease 
- Don't know or incorrect 
- Correct but incomplete 
- Correct and complete 
 
21 
28 
1 
 
42.0 
56.0 
2.0 
 
34 
15 
1 
 
68.0 
30.0 
2.0 
Diseases' symptoms 
- Don't know or incorrect 
- Correct but incomplete 
- Correct and complete 
 
9 
25 
16 
 
18.0 
50.0 
32.0 
 
22 
17 
11 
 
44.0 
34.0 
22.0 
Complications of disease 
- Don't know or incorrect 
- Correct but incomplete 
- Correct and complete 
 
12 
21 
17 
 
24.0 
42.0 
34.0 
 
30 
10 
10 
 
60.0 
20.0 
20.0 
 Effect of iron precipitation 
- Don't know or incorrect 
- Correct but incomplete 
- Correct and complete 
 
29 
20 
1 
 
58.0 
40.0 
2.0 
 
 34 
15 
1 
 
68.0 
30.0 
2.0 
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Table (4): Factors related knowledge of TM children and their mothers about treatment plan 
Factors Mothers 
( n= 50 ) 
TM Children 
( n= 50) 
No % No % 
Importance of treatment with Desferal  
- Don't know or incorrect 
- Correct but incomplete 
- Correct and complete 
 
25 
25 
0 
 
50.0 
50.0 
0.0 
 
34 
16 
0 
 
68.0 
32.0 
0.0 
How many times desferal should be taken? 
- Don't know or incorrect 
- Correct but incomplete 
- Correct and complete 
 
21 
25 
4 
 
42.0 
50.0 
8.0 
 
27 
20 
3 
 
54.0 
40.0 
6.0 
Side effect of desferal 
- Don't know or incorrect 
- Correct but incomplete 
- Correct and complete 
 
31 
19 
0 
 
62.0 
38.0 
0.0 
 
35 
15 
0 
 
70.0 
30.0 
0.0 
Precautions to avoid desferal side effects  
- Don't know or incorrect 
- Correct but incomplete 
- Correct and complete 
 
32 
18 
0 
 
64.0 
36.0 
0.0 
 
 46 
4 
0 
 
92.0 
8.0 
0.0 
Hb level required for blood transfusion 
- Don't know or incorrect 
- Correct but incomplete 
- Correct and complete 
 
28 
22 
0  
 
56.0 
44.0 
0.0 
 
40 
10 
0 
 
80.0 
20.0 
0.0 
Importance of blood transfusion 
- Don't know or incorrect 
- Correct but incomplete 
- Correct and complete 
 
25 
25 
0 
 
50.0 
50.0 
0.0 
 
34 
16 
0 
 
68.0 
32.0 
0.0 
Complication of stopping blood transfusion 
- Don't know or incorrect 
- Correct but incomplete 
- Correct and complete 
 
27 
23 
0 
 
54.0 
46.0 
0.0 
 
37 
13 
0 
 
74.0 
26.0 
0.0 
Complication of recurrent blood transfusion 
- Don't know or incorrect 
- Correct but incomplete 
- Correct and complete 
 
13 
34 
3 
 
26.0 
68.0 
6.0 
 
25 
24 
1 
 
50.0 
48.0 
2.0 
Causes of sever complications 
- Don't know or incorrect 
- Correct but incomplete 
- Correct and complete 
 
12 
36 
2 
 
24.0 
72.0 
4.0 
 
32 
17 
1 
 
64.0 
34.0 
2.0 
Meaning of commitment to treatment plan 
- Don't know or incorrect 
- Correct but incomplete 
- Correct and complete 
 
13 
37 
0 
 
26.0 
74.0 
0.0 
 
28 
22 
0 
 
56.0 
44.0 
0.0  
Importance of commitment to treatment plan 
- Don't know or incorrect 
- Correct but incomplete 
- Correct and complete 
 
13 
37 
0 
 
26.0 
74.0 
0.0 
 
25 
25 
0 
 
50.0 
50.0 
0.0 
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Table (5): Relationship between importance of commitment to treatment plan and sociodemographic 
characteristics of TM children and their mothers. 
Sociodemographic Characteristics 
 
Mother's knowledge about the 
importance of commitment to 
treatment plan (n = 50) 
TM children knowledge about 
the importance of commitment 
to treatment plan (n = 50) 
Don't know or 
incorrect 
Correct but 
incomplete 
Don't know or 
incorrect 
Correct but 
incomplete 
No. % No. % No. % No. % 
Mother education 
Illiterate 
Read & write 
Secondary 
University 
 
8 
3 
2 
0 
 
42.1 
50.0 
8.7 
0.0 
 
11 
3 
21 
2 
 
57.9 
50.0 
91.3 
100.0 
 
8 
4 
11 
2 
 
32.0 
16.0 
47.8 
100.0 
 
11 
2 
12 
0 
 
44.0 
8.0 
52.1 
0.0 
 (p value) .045 .139 
Mother occupation 
Working 
Not working 
 
3 
10 
 
33.3  
24.4 
 
6 
31 
 
66.6 
75.6 
 
6 
19 
 
66.6 
46.3 
 
3 
22 
 
33.3 
53.7 
 (p value) .580 .269 
Residence 
Urban  
Rural 
 
11 
2 
 
36.7 
10.0 
 
19 
18 
 
63.3 
90.0 
 
15 
10 
 
50.0 
50.0 
 
15 
10 
 
50.0 
50.0 
 (p value) .035 1.000 
Family monthly income 
Sufficient and save  
Sufficient 
Insufficient 
 
0 
9 
4 
 
 
0.0 
39.1 
19.1 
 
6 
14 
17 
 
100.0 
60.9 
80.9 
 
5 
13 
7 
 
83.3 
65.5 
33.3 
 
1 
10 
14 
 
16.7 
43.5 
66.7 
 (p value) .096 .067 
 
Figure (6):Relationship between disease related knowledge of TM children and their mothers and their 
commitment to treatment plan. 
 
Commitment to treatment plan 
 
Disease related knowledge of 
studied children and their 
mothers   
 
 
Total 
Week 
Knowledge 
Moderate 
knowledge 
No. % No. % No. % 
Moderate Commitment     
3 
 
 
6.0 
 
 
30 
 
 
60.0 
 
 
33 
 
66.0 
Strong Commitment 4 
 
8.0 
 
13 
 
26.0 
 
17 34.0 
(p value) .000 
 
Results 
Sample sociodemographic characteristics of both thalassemic patients’ and mothers’ knowledge, treatment 
adherence, the relationships between knowledge and treatment adherence in patients; are as follows. 
Regarding the thalassemic children, fifty thalassemic child, aged 10–18 years, (mean±SD = 13.74±2.107), were 
included. Most patients were male (66%), more than half of TM children were from rural area. Concerning TM 
children mother's, fifty mothers were included (40%) of them aged 20-30 years while mothers aged 40 years or 
more were (36.0%). Thirty eight percent of mothers were illiterate while (40%) percent of them were Diplomat 
education and only 4.0% were university education. Majority of mothers (82.0%) were not working and (42.0%) 
of them had insufficient monthly income and only 12.0% of them had sufficient income and could save based on 
the self-report of mothers (table 1). 
About family history of thalassemia (36%) of TM patients had consanguinity relation with relative in the first 
degree who had the disease (table 2)  Regarding the sports which practiced by TM patients , it was found that 
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(56%) of TM patients practiced sports and walking was the most sport type practiced by 32% of TM patients. 
The majority of TM patients (88%) felt tired after exerting effort. Half of TM patients (50%) had dyspnea and 
18 % of them had sweat as manifestations of tiredness after exerting effort.   
According to the disease knowledge in both TM patients and their mothers (table 3), about two thirds of mothers 
(64%) and (76%) of TM patient didn't know or gave incorrect answer about the definition of thalassemia. More 
than half of mothers (54%), and more than one third (40%) of TM patients answered correct and complete about 
the item of thalassemia prevalence while about one half (46%), and about two thirds (60%) of mothers and TM 
patients respectively didn't know or gave incorrect answer. Concerning the disease risk factors item, the majority 
of mothers (56%) and nearly one third (30%) of TM patients didn't know or answered incorrectly. Forty two 
percent of mothers and twenty percent of TM patients answered correct but incomplete about complications of 
disease item, while (34%), and (20%) of mothers and TM patients respectively their answers were complete and 
correct. Regarding mothers and TM patient knowledge about the effect of iron precipitation, only 2%  answered 
correctly and completely.  
Concerning mothers and TM patient's knowledge about treatment plan (table 4), half of mothers (50%) and 
majority of TM patients (68%) didn't know or gave incorrect answer, while non of them answered in correct or 
complete about the importance of treatment with desferal. Half of mothers (50%) and less than half of TM 
patients (40%) gave correct but incomplete answer about how many times Deciferal should be infused. 
Regarding their knowledge about side effect of desferal majority of mothers and TM patients (62%), (70%) 
respectively didn't know or answered incorrectly, on the other hand non of them gave correct or complete answer. 
None of the mothers or TM patients answered correctly and completely about precautions to avoid desferal side 
effects, while only 8% of TM patients answered correctly but incomplete. Concerning the item of required Hb 
level  for blood transfusion, more than half of mothers (56%) and majority of patients (80%) didn't know or gave 
incorrect answer, while none of them answered correctly or completely. Concerning the importance of blood 
transfusion, half of mothers (50%) and more than two thirds (68%) of TM patients answered incorrectly, 50% of 
mothers and 32% of TM patients answered correctly but not complete about these item.  As regard the item of 
stopping blood transfusion complications knowledge, more than half of mothers (54%) and about three fourths 
of TM patients (74%) answered incorrectly or didn't know the answer, while none of them know the correct 
answer. Sixty eight percentage and forty eight percentage of mothers and TM patients respectively, gave correct 
but incomplete answer about the item of complications of repeated blood transfusion. 
When mothers and TM patients were asked about the importance of commitment to treatment plan (table 4), 
about one quarter (26%) of mothers and one half (50%) of TM patients answered incorrectly or didn't know, and 
(74%), (50%) of mothers and TM patients respectively answered correctly but incomplete and none of them 
know the correct and complete answer. 
Relationships between TM patients and their mothers’ knowledge about the importance of compliance of 
treatment plan, it was found that there was statistical significant difference between mothers' knowledge about 
importance of commitment to treatment plan and their educational level ( p=0 .04*) , and residence (p=0.03*) 
(table 5). 
According to  the relation between the sample knowledge and their compliance to treatment plan (table 6), it was 
found that , moderate commitment was apparent in 6%  of sample with week knowledge and 60% of sample 
with moderate knowledge while, strong commitment was found in 8% of sample with week knowledge and in 
26% of them with moderate knowledge. This relation was highly statistically significant (p= .000). 
 
Discussion: 
    The present study showed that more than half of the studied children were males. This finding is in consistent 
with the findings of Elsaid (2009) who done his study at Zagazig university Hospitals, Zagazig, Egypt and 
Salama et al (2006) who done his study at Mansoura University Children's Hospital, Mansoura, Egypt. The 
present study is also supported by Shaligram et al (2007) who done his study in Shiraz city. Similar to Shaligram 
et al (2007), the present study showed that about two thirds of children were from rural area. On other hand, the 
current study is in contrast with Gharaibeh et al (2009) who done his study at the National Thalassemic Center in 
Damascus, Syria. Gharaibeh study illustrated that about three quadrants were from urban. This reflects that 
thalassemia may be presented in urban as in rural when premarital screening and genetic counseling is neglected. 
In addition, the data was collected from Pediatric Hematology Outpatient Clinic at Zagazig University Hospital 
that represents the only center serving thalassemic patients all over Sharkia Governorate for free and attracts 
patients from all villages of the governorate. 
      The current study found that most families reported insufficient and sufficient family income. This finding 
goes in line with the findings of Gharaibeh et al (2009). This may explain that only poor families are more likely 
to take their children to general hospitals, or may reflect that rich families have enough money to make 
premarital and prenatal screening tests when they are knowledgeable about it.    
      Shaligram et al (2007) noticed that about half of the cases were outcomes of first-or second-cousin marriages. 
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Also, Naseri (1997) revealed in his study that 66% of thalassemic children had consanguineous parents. This 
goes in line with the present study which revealed that more than half of parents of the studied children were 
relatives. This may be due to strong family relationships in Egypt, especially those who live in rural areas and 
that the closer the relation between the parents, the greater the risk that many children might be born with a 
hereditary disorder such as thalassemia.  
Tadmouri et al. (2012) stated that Arab populations have a long tradition of consanguinity, due to sociocultural 
factors such as maintenance of family structure and property, and ease of marital arrangements. Many Arab 
countries display some of the highest rates of consanguineous marriages in the world, specifically first cousin 
marriages. The main impact of consanguinity, however, is an increase in the rate of homozygotes for autosomal 
recessive genetic disorders such as thalassemia. In addition, educational programs about genetic counseling are 
still neglected. 
Eleftheriou (2007) clarifies that about 2-3 children in every 1,000 born to unrelated parents have a recessive 
disorder, while from 2-20 children in 1,000 born to related parents have a recessive disorder, depending on how 
closely the parents are related.  
      Gharaibeh et al (2009) found that more than two thirds of children had sick relatives with thalassemia. This 
goes in line with the present study where more than half of children had family history of thalassemia. This may 
be the result of increased consanguineous marriages.  
Many factors can affect daily living physical activities in thalassemic patients such as chronic hypoxia that 
results from progressive anemia and leads to decreased exercise tolerance (Hockenberry & Wilson, 2009). The 
results of the present study showed that less than half (44%) of the thalassemic patients practiced some kind of 
sports or activities and 16% those played football. The male predominance among the studied sample played a 
role in this result as well as the predominance of this age group, since they tempted to risk-taking behaviors, 
especially males. 
The current study reveled that about one third of thalassemic patients had no problem with walking, this is goes 
in line with Shaligram et al (2007) who found that the majority of children had no problems with mobility.On the 
other hand, more than half (56%) of the thalassemic patients did not practice any kind of sports or activities. As a 
result of fear of feeling tired and exhausted after doing any effort as the main cause of not practicing sports or 
activities. This is goes in line with Khurana et al. (2006) who studied the psychosocial life aspects of Indian 
adolescents suffering from β-thalassemia major and reported that over two thirds of the adolescents were unable 
to engage in outdoor play at the same level as their peers, because of physical weakness related to their disease. 
Indulgence in sport activities was therefore limited.     Also, Caro (2002) who found that, less than one quadrant 
of conventionally treated thalassemia major patients had their activities very often stopped due to thalassemia, its 
complications or desferrioxamine treatment, and 20% had their physical activities limited at least a bit. This may 
be due to the regular period of mild anemia before the scheduled of transfusion which might limit their exercise 
capacity as thalassemia leads to low hemoglobin level resulting in fatigue and general weakness   (Cheuk et al, 
2008).   
 
Regarding to thalassemic patients and their mothers knowledge about definition of thalassemia, about two thirds 
(76%) and  (76%) of them respectively were not able to define thalassemia correctly or gave incomplete answer. 
This is may return to lack of health education about the disease itself and that the health team either doctors or 
nurses tend to give more health instructions about the care practices than the disease. El-Awany (2002) and 
Hassan (2009) were in agreement with these results. They noted that most of the children had wrong information 
regarding definition of thalassemia before implementation of the educational programs, and there was a 
significant improvement of knowledge after implementation of the educational programs in both studies.  
 
The results of the present study revealed that only twenty percentage of thalassemic patients and thirty four 
percentage of their mothers answered complete and correctly. Yang et al. (2005) supported these findings and 
reported that, the worst knowledge score in his study was the knowledge of complications. The bad knowledge 
about complications in the present study may be explained through the fact that, many patients avoid receiving 
complications-related information owing to distress about an uncertain future. 
 
In a study conducted to explore the relationships among illness knowledge, social support and self-care behavior 
in adolescents with β-thalassemia major in Taiwan, Yang et al. (2005) reported that treatment knowledge was the 
best among the scores of illness knowledge. This was not the case in the present study where more than half of 
mothers and majority the thalassemic patients were not able to give correct answer or don't know importance of 
desferal to treat thalassemia.  
 
Hashem (2006) noticed that, thalassemic children had average level of understanding the importance of blood 
transfusion therapy before educational program implementation. After their attendance and participatio
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program, they gained more knowledge about the importance of blood transfusion therapy. In the current study, 
regarding importance of blood transfusion half of mothers (50%) and about one third of thalassemic patients 
(32%) answered correctly but incomplete as regard the importance of blood transfusion to improves general 
health, increases activity, provides energy, prevents blood destruction and prevents fatigue.  
The previously mentioned incorrect answers originated from the fact that the some of the thalassemic patients 
did not have blood transfusion unless their hemoglobin level become very low and start to suffer from hypoxic 
manifestations [headache, precordial pain, bone pain, decreased exercise tolerance, listlessness and anorexia 
(Hockenberry & Wilson, 2009) and these manifestations improved significantly after the blood transfusion and 
this was clear in their understanding of the blood transfusion importance.  
 
 
In the current study, the hemoglobin (Hb) level that required for blood transfusion in thalassemic patients was 
not known to more than half of the mothers and majority of thalassemic patients. This is contradicted with Lee et 
al. (2008) who reported that more than three quarters of his studied patients were able to determine the mean Hb 
level (9-10.5 g/dl) that required in thalassemic patients for transfusion. Lack of knowledge observed among 
thalassemic patients in the current study may be due to two reasons (i) inadequate explanation from health-care 
providers and/or (ii) most of the patients and their mothers believed that investigations, Hb level and treatment 
issues are the responsibility of the physician and they do not need to know a lot about it (iii) poor socioeconomic 
status of most of the studied patients and getting sick of so many needles they had to have during treatment 
process. Porter, 2011 stated that monitoring pre-transfusion Hb level is very important to prevent complications. 
 
Concerning the studied thalassemic patients and their mothers knowledge about side effects of desferal, it was 
found that, the side effects of desferal were not known to more than half of the mothers (62%) and majority of 
the thalassemic patients (70%). This is may be due to the belief that, if the patient knows the possible side effects 
of the drug they will be afraid of taking it and consequently will not comply with it. So, health care providers 
usually tend to avoid the discussion of medication’s side effects with the patients. Moreover, the pamphlets of all 
iron chelating agents were written in English language, that the studied patients cannot read or understand. 
Same knowledge deficit regarding chelation therapy was reported by EL-Awany (2002) who found that, 
thalassemic children and their mothers lacked the essential knowledge in this area before implementation of the 
educational program. Nevertheless, after implementation of the health instructions, thalassemic adolescents’ 
knowledge improved significantly regarding side effects of desferal, kelfer, ferriprox and exjade. 
 
As regards the thalassemic patients and their mothers knowledge about importance of compliance with treatment 
plan, majority of mothers (74%) and half of thalassemic patients (50%) answered correctly but incomplete about, 
compliance with treatment decrease iron overload. This is congruent with Lee et al. (2008) who reported that, the 
majority of his studied patients stated that, importance of compliance with iron chelators is to get rid of excess 
iron and to avoid iron sedimentation. This may be due to, the stress of physicians’ instructions on the importance 
of iron chelators in reducing iron overload. 
 
This study shows that TM patients and their mothers’ knowledge about the importance of compliance of 
treatment plan and mother's education was statistically significant relation ( p=.045), mothers’ knowledge about 
TM is dependent on mother's educational level and that is the most significant variable influencing patients’ 
knowledge. This supports the literature: In a survey of 38 patients with TM and their mothers, Aydinok et al. 
(2005) reported that mothers’  educational and psychological burden correlated with the patients’ mental status 
and that the more disease awareness possessed by both mothers and patients, the more compliant patients were to 
related treatment. It is not surprising that the effect of mothers’ knowledge on patients’ knowledge is 
tremendously significant as mothers are the main caregivers. Teaching and research should therefore pay 
attention to educating patients’ mothers about TM in their children.  
 
There was no significant relationships between TM patients and their mothers’ knowledge about the importance 
of compliance of treatment plan and family monthly income ( p=.096). In the past, funding was a serious issue 
during the TM treatment. This expenditure was a huge burden for a middle-class family. This cost may have 
deterred patients and their families from taking DFO infusions on schedule. They may have instead chosen to 
inject DFO only when serum ferritin accumulated and exceeded the normal range. After  implementation of the 
Egyptian National Health Insurance .Economic limitation as a factor is expected to have been reduced. Moreover, 
the efforts of several patient and social support associations, might have helped to improve patients’ adherence to 
blood transfusions and DFO infusions.  
      The present study found that moderate commitment was found in 6% of studied children and their mothers 
who had week knowledge and 60% of them with moderate knowledge while, strong commitment was apparent 
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in 8% of the studied sample with week knowledge and in 26% of them with moderate knowledge. This finding 
gives an objective indicator to assess the level of disease knowledge in TM patients and their mothers. Patients 
with poor compliance to treatment plan may have less TM knowledge.  
This finding is supported by Elsaid (2009) who done his study at Zagazig university Hospitals, Zagazig, Egypt 
and he found the most of his studied sample were not complaint with iron-chelation therapy. Poor knowledge of 
thalassemic patients and their mothers regarding the disease, and the treatment plan, is a multifaceted issue. As, it 
may be owing to; excessive anxiety, fear of condition, illiteracy, impaired communication, lack of prior teaching, 
misinterpretation of information and unwillingness to learn. In addition, lack of adequate guidance by the health 
care providers and lack of effective communication between the nursing staff and the patients also play a role in 
this knowledge deficit. In the study setting, (Hematology Outpatient Clinic) there is a shortage in the nursing 
staff number especially the highly qualified nurses, who supposed to be able to give adequate explanation about 
the disease and its care aspects. This shortage in the nursing staff number represents another important issue in 
this problem. 
Conclusion 
Based upon the findings of the current study, it can be concluded that, positive association between knowledge 
about disease and treatment adherence and factors of patients’ knowledge indicate the need for systematic 
education for patients and caregivers to improve their compliance with treatment.  
Recommendations: 
 
 Improvement of the quality of patient care, reinforcement of medical education and enhanced efforts by 
clinical staff to provide practical knowledge to children with thalassemia major and their parents is 
mandatory to significantly improve patient compliance to treatment. 
 Age-appropriate cartoon illustrations for children to provide detailed scientific information about the 
disease and how to survive with it.  
 The pediatric health nurses should be specially trained to act as genetic counselors to reduce the 
incidence of thalassemia and should be able to discuss important aspects of prevention.  
 Mass media must provide population with genetic counseling about thalassemia and other inherited 
diseases and discourage consanguineous marriage. 
 Further researches are needed to investigate factors affecting compliance with treatment regimen. 
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